DSwiss provides turnkey private label manufacturing services for nutraceutical and skincare/personal care products, offering ODM/OEM services ranging from research and development of custom formulation, manufacturing and production, packaging and shipping. The company targets the high-growth ASEAN region with a diversified product portfolio spanning functional foods, cosmetics, and pet care.
Cyborg Score Rationale
DSwiss operates with minimal market capitalization ($2.6M), trades on OTC markets with limited liquidity, and lacks publicly available recent financial data or major development announcements. The company faces significant scale challenges and information asymmetry typical of micro-cap OTC stocks.
Top Insights
Specialized in private label manufacturing (ODM/OEM) rather than branded consumer products, positioning as a B2B service provider
Geographic focus on high-growth ASEAN markets provides exposure to expanding middle-class wellness and beauty consumption
Extremely small market capitalization ($2.6M) limits capital for expansion, R&D, and marketing initiatives
OTC trading status and lack of recent disclosures suggest minimal institutional interest and weak information flow to investors
Named Competitors
Estée Lauder — Premium beauty and skincare products
Unilever — Personal care and beauty portfolio (ASEAN presence)
Regional ODM/OEM Manufacturers — Contract manufacturing for beauty and nutraceutical brands
Open the full interactive DSwiss Inc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.